Drug utilisation and incident rates of adverse events in children with sialorrhoea who are treated with glycopyrronium (Glyco Sialorrhoea)

18/07/2022
23/04/2024
EU PAS number:
EUPAS48222
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information